Bruce Jacobs, CFA, MBA, is the Chief Financial Officer at KYMERA THERAPEUTICS INC, a position he has held since joining the company in 2020. With an extensive background in finance and biotechnology, Jacobs has been instrumental in guiding KYMERA through its growth and development phases. He holds a Master of Business Administration from Harvard Business School and is a Chartered Financial Analyst, credentials that have significantly contributed to his expertise in financial strategy and management within the biotech industry. Prior to his role at KYMERA THERAPEUTICS INC, Jacobs held several high-profile positions in the financial sector. He spent over a decade at major investment banks, where he specialized in healthcare and life sciences. During his tenure, he led numerous successful financings and mergers and acquisitions, which enhanced his reputation as a strategic thinker and financial leader. His experience in these areas has been pivotal in his current role, where he oversees KYMERA's financial operations, strategic planning, and investor relations. At KYMERA THERAPEUTICS INC, Jacobs plays a critical role in steering the company towards its mission of developing novel therapies for serious diseases. His strategic financial planning has been crucial in securing funding for the company's innovative research and development projects. Under his leadership, KYMERA has successfully navigated the complex financial landscape of the biotech industry, ensuring sustainable growth and a strong financial position. Jacobs' dedication to advancing KYMERA's goals, combined with his profound financial acumen, continues to drive the company forward in its quest to bring transformative treatments to patients worldwide.